Two Amgen EPO Patent Infringement Claims Upheld By Federal Appeals Court
This article was originally published in The Pink Sheet Daily
Executive Summary
In a mixed decision, the appeals court also reversed a lower court's decision that rival drug makers had infringed a different patent.
You may also be interested in...
Amgen Knocks Roche In Early Round Of EPO Court Fight
Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.
Amgen Knocks Roche In Early Round Of EPO Court Fight
Federal judge rules that Roche’s EPO product Mircera infringes a key Amgen patent, although trial is still set for Sept. 4.
Amgen Bundling Discounts Will Continue As J&J Case Heads To Trial
Court denies injunction sought by J&J to stop Amgen discounts based on amount of anemia products purchased.